RemedyRepack Inc. is recalling one vial of Metoprolol Tartrate Injection, USP 5mg/5mL, a prescription medication used to treat high blood pressure and chest pain. This recall was initiated after stability testing revealed that the medication's pH levels were outside of the required safety specifications. Only a single vial was distributed to a medical facility in Mayville, New York, but consumers who may have received this medication should be aware of the potential for reduced effectiveness or safety concerns.
The pH level of an injectable medication is critical for its stability and compatibility with the human body; levels that are too high can cause the drug to break down prematurely or potentially cause irritation at the injection site. No injuries or adverse incidents have been reported to date regarding this specific unit.
Healthcare consultation and refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.